Skip to main content
. 2019 Aug 29;10:1997. doi: 10.3389/fmicb.2019.01997

TABLE 4.

Amount of aflatoxin B1 (ng/mL) produced in growth medium amended with phenolic extract (PE) and lipophilic extract (LE) at different concentrations.

4 DAI 5 DAI 6 DAI 7 DAI
ctr + 344.37 ± 17.28A 951.94 ± 46.8A 1479.47 ± 73.6A 2207.29 ± 109.5A
PE 500 ng/mL 0F 0F 0G 0E
PE 100 ng/mL 0F 0F 93.01 ± 4.65F 157.01 ± 7.26D
PE 50 ng/mL 0F 77.33 ± 3.48E 107.54 ± 5.34F 170.60 ± 8.45D
LE 100 μg/mL 84.50 ± 4.22E 180.67 ± 9.15D 364.23 ± 18.84C 725.45 ± 35.72B
LE 10 μg/mL 113.40 ± 5.62D 207.44±10.42DC 209.41 ± 11.01E 244.15 ± 12.94D
LE 1 μg/mL 0F 233.45 ± 11.75C 274.90 ± 13.81D 535.01 ± 26.88C
PE 50 ng/mL + LE 1 μg/mL 172.28 ± 8.59C 216.16 ± 10.79CD 200.68 ± 10.82E 619.10 ± 29.61C
PE 50 ng/mL + LE 10 μg/mL 311.88 ± 14.7B 356.79 ± 18.84B 389.97 ± 19.59C 742.48 ± 36.98B
PE 100 ng/mL + LE 10 μg/mL 180.89 ± 9.12C 192.07 ± 9.53D 465.77 ± 23.56B 726.72 ± 34.87B

Values are reported as means ± SD. AFB1 production was monitored: 4, 5, 6, and 7 DAI. Negative control (ctr−) and positive control (ctr+) corresponded, respectively, to non-inoculated growth medium amended with extracts, and infected growth medium without extracts. Small capital letter in the charts represent the significantly different groups (p < 0.05; Tukey test).